Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

4-Traders Homepage  >  Equities  >  Nyse  >  Actavis Inc    

SummaryNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
News SummaryMost relevantAll newsSector newsTweets 
Latest news on ACTAVIS INC
2016 SoftBank bid for ARM catches some hedge funds off guard
2016DJTEVA PHARMACEUTICAL : Sells $15 Billion of Bonds
2016DJTEVA PHARMACEUTICAL : Finalizes Bond Sale -- Update
2016DJTEVA PHARMACEUTICAL : Finalizes Bond Sale
2016DJTeva Sells $15 Billion of Bonds
2016DJTEVA PHARMACEUTICAL : Allergan Tweak Acquisition Agreement
2016DJTEVA PHARMACEUTICAL : Allergan Tweak Acquisition Agreement
2016DJTeva Raises Guidance
2016DJTEVA PHARMACEUTICAL : Raises Guidance
2016 Shire on a roll as U.S. approves keenly awaited eye drug
2016 EXCLUSIVE - WELLCARE, CENTENE MAKE O : sources
2016DJMayne Pharma Buys US Drugs from Teva, Allergan for $652 Million
2016DJTeva and Allergan Sell Generic Drugs to Impax In Latest Divestiture
2016DJTeva and Allergan Sell Generic Drugs to Impax In Latest Divestiture
2016DJALLERGAN : Former Warner Chilcott Executive Acquitted of Kickbacks Charge
2016DJTeva, Looking to Close Actavis Deal, Sells $40 Million Portfolio to Sagent
2016DJLILLY : German Supreme Court Grants Appeal in Dispute With Actavis
2016DJALLERGAN : Icahn Takes Big Stake in Allergan, Endorses Drugmaker's CEO
2016 Anacor received rival bid before Pfizer deal - filing
2016DJPfizer Buys Anacor In Turn to Smaller Deals -- WSJ
2016DJPfizer to Buy Anacor for $4.5 Billion--2nd Update
2016DJPfizer to Buy Anacor for $4.5 Billion--Update
2016DJPfizer to Buy Anacor for $4.5 Billion
2016DJPfizer to Buy Anacor for $4.5 Billion
2016 Baupost took $461 million Allergan stake before Pfizer deal collapsed
2016DJMarkit's Profit Falls on Higher Personnel Costs
2016DJALLERGAN : Uterine Fibroids Treatment Shows Efficacy
2016DJTEVA PHARMACEUTICAL : Revenue Declines as Some Drugs Lose Exclusivity
2016DJEndo Cuts Annual Guidance on Impairment Charge
2016DJPFIZER : Reports Rock-Solid Quarter, Sees Stronger Year Ahead
2016DJPfizer Guides Higher, Mulls Breakup of Company
2016DJNew Tax Inversion Rules Complicate Equipment-Maker Deal
2016DJJOSEPH PAPA : Valeant Names Joseph Papa as New CEO
2016DJAllergan Completes Licensing Deal After Pfizer Bid Collapses
2016DJAllergan Completes Licensing Deal After Pfizer Bid Collapses
2016 Mega deals morph into mega problems for Wall Street
2016DJPfizer, Allergan to Hunt for Deals of Their Own
2016 Oil, healthcare boost stocks; dollar weak after minutes
2016 Oil, healthcare boost global stocks; dollar weak after minutes
2016DJPFIZER : Treasury Has Outsize Legal Leverage on Inversions
2016DJFDA Approves Medtronic Pacemaker That Attaches Directly to Heart
2016 Mega-deal collapse a second-quarter wake-up for merger-arb hedge funds
2016DJAllergan CEO Saunders Criticizes Treasury Rules That Scuttled Pfizer Deal
2016DJPFIZER : Allergan End Merger Agreement -- 2nd Update
2016 Democratic White House hopefuls cheer end of Pfizer, Allergan deal
2016 Pfizer, Allergan scrap $160 billion deal after U.S. tax rule change
2016 Pfizer, Allergan scrap $160 billion deal after U.S. tax rule change
2016DJMedtronic Says New Inversion Rules Won't Hurt Finances
2016DJPFIZER : Files 8K - Termination Of Definitive Agreement
2016DJPfizer, Allergan End Merger Agreement -- Update
2016DJPfizer Walks Away From Allergan Deal
2016DJPFIZER : Drops Allergan Takeover -- WSJ
2016DJHealth-Care Companies Lead U.S. Stocks Higher
2016 Obama's inversion curbs kill Pfizer's $160 billion Allergan deal
2016DJPFIZER : to Walk Away From Allergan Deal
2016DJPFIZER : to Walk Away From Allergan Deal
2016 Dollar touches 17-month low vs yen as stocks slump
2016 Obama urges Congress to take action on corporate tax reform
2016 Dollar drops to 17-month low vs. yen as stocks slump
2016 EXCLUSIVE : Pfizer leaning towards abandoning deal with Allergan - source
2016 EXCLUSIVE : Pfizer leaning toward abandoning deal with Allergan - source
2016DJU.S. HOT STOCKS : Hot Stocks to Watch
2016DJPFIZER : U.S. Sets Tougher Rules On Tax Deals
2016 New U.S. inversion rules threatens Pfizer-Allergan deal
2016 New U.S. inversion rules threatens Pfizer-Allergan deal
2016DJPFIZER : New Rules on Tax Inversions Threaten Pfizer-Allergan Deal -- 3rd Update
2016 Wall Street pulls back after recent rally
2016DJPFIZER : New Rules on Tax Inversions Threaten Pfizer-Allergan Deal -- 2nd Update
2016DJPFIZER : New Rules on Tax Inversions Threaten Pfizer-Allergan Deal -- Update
2016DJNew Rules on Tax Inversions Threaten Pfizer-Allergan Deal
2016DJPFIZER : Cholesterol Drug Meets Co-Primary Endpoints in Latest Study
2016 U.S. FTC sues Endo alleging antitrust violations
2016DJFTC Accuses Endo of Paying Off Generic Drugmakers
2016DJFTC Seeks More Information on Pfizer-Allergan Merger
2016DJPFIZER : FTC Seeks More Information on Pfizer-Allergan Merger
Prev.1   2  3  4  5  6  7  8  9  10Next
Advertisement
Financials ($)
Sales 2016 14 487 M
EBIT 2016 7 207 M
Net income 2016 -901 M
Debt 2016 22 566 M
Yield 2016 -
P/E ratio 2016 -
P/E ratio 2017 67,85
EV / Sales 2016 7,12x
EV / Sales 2017 6,44x
Capitalization 80 575 M
More Financials
Income Statement Evolution
More Financials
Consensus 
Mean consensus OUTPERFORM
Number of Analysts 22
Average target price 259 $
Spread / Average Target 20%
Consensus details
EPS Revisions
More Estimates Revisions
Managers
NameTitle
Brenton L. Saunders Chairman, President & Chief Executive Officer
Robert A. Stewart Chief Operating Officer
Maria Teresa Hilado Chief Financial Officer
C. David Nicholson Chief Research & Development Officer
Paul M. Bisaro Director
More about the company
Sector and Competitors
1st jan.Capitalization (M$)
ACTAVIS INC80 575
JOHNSON & JOHNSON-1.13%309 896
ROCHE HOLDING LTD.0.39%200 025
PFIZER INC.-3.14%190 910
NOVARTIS AG-4.32%183 809
MERCK & CO., INC.4.99%170 419
More Results